-
Je něco špatně v tomto záznamu ?
Does the administration of antioxidants as scavengers of reactive oxygen species in kidney transplantation really have sense?
V Kuntscher, V Treska, J Racek, J Kobr, L Trefil, O Hes
Jazyk angličtina Země Slovensko
Grantová podpora
NR7913
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- antioxidancia aplikace a dávkování farmakologie MeSH
- financování organizované MeSH
- intravenózní infuze MeSH
- reaktivní formy kyslíku metabolismus MeSH
- reperfuzní poškození metabolismus prevence a kontrola MeSH
- scavengery volných radikálů aplikace a dávkování farmakologie MeSH
- Sus scrofa MeSH
- transplantace ledvin MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
BACKGROUND: The aim of the study was to evaluate the degree of ischemia reperfusion syndrome (IRS) in serious ischemic insult of a kidney transplant and to try to mitigate the production of reactive oxygen substances (ROS) and inflammatory response. METHODS: The study was performed on 14 white pigs (20 kg). The pigs were divided in couples using a negative cross-matching and the couples were divided into the two groups. Each animal from the compatible couple was a donor/recipient of a kidney to/from the counterpart. Group II (TxII) received the intravenous antioxidants. Group I (TxI) was a control group. L-ascorbic acid 125 mg, selenium 4.4 mg, tocoferol 50 mg and N-acetyl-cysteine 200 mg were used as the antioxidants. They were applied intravenously to the TxII animals for 20 minutes before reperfusion of a kidney transplant. A serious ischemic insult was created by the left kidney hilum's cross-clamping for 30 min before donation. After the kidneys' removal, the left ones were flushed with Histidine Tryptophan Ketoglutarate (HTK) preservation solution and transplanted after the 1.5 hour (in the meantime stored in melted ice). Venous blood samples were taken for the assessment of malondialdehyde (MDA), reduced glutathione (GSH), glutathioneperoxidase (GSHPx), antioxidative capacity of plasma (AOC), interleukin 6 (IL-6), and tumor-necrosis factor alfa (TNFalfa) prior to the nefrectomy, before application of ROS scavengers (TxII), and during the 120-minute period after the transplantation (TxL+TxII). RESULTS: There wasn't a significant difference neither in production of MDA, nor in the levels of GSH, GSHPx, AOC, IL6 and TNFalfa between the TxI and TxII groups. CONCLUSIONS: Based on our results, we cannot conclude that the intravenous application of ROS scavengers in given combination and amount, administered to the recipient in the period just before transplantation, is a useful protective mechanism against kidney damage during IRS (Fig. 3, Ref. 17). Full Text (Free, PDF) www.bmj.sk.
- 000
- 03643naa 2200397 a 4500
- 001
- bmc10034943
- 003
- CZ-PrNML
- 005
- 20130919101329.0
- 008
- 101221s2007 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Kuntscher, Vilém, $d 1966- $7 xx0081969
- 245 10
- $a Does the administration of antioxidants as scavengers of reactive oxygen species in kidney transplantation really have sense? / $c V Kuntscher, V Treska, J Racek, J Kobr, L Trefil, O Hes
- 314 __
- $a Transplantation Centre, Medical Faculty Plzen, Charles University Prague, University Hospital Plzen, Czech Republic. kuntscher@fnplzen.cz
- 520 9_
- $a BACKGROUND: The aim of the study was to evaluate the degree of ischemia reperfusion syndrome (IRS) in serious ischemic insult of a kidney transplant and to try to mitigate the production of reactive oxygen substances (ROS) and inflammatory response. METHODS: The study was performed on 14 white pigs (20 kg). The pigs were divided in couples using a negative cross-matching and the couples were divided into the two groups. Each animal from the compatible couple was a donor/recipient of a kidney to/from the counterpart. Group II (TxII) received the intravenous antioxidants. Group I (TxI) was a control group. L-ascorbic acid 125 mg, selenium 4.4 mg, tocoferol 50 mg and N-acetyl-cysteine 200 mg were used as the antioxidants. They were applied intravenously to the TxII animals for 20 minutes before reperfusion of a kidney transplant. A serious ischemic insult was created by the left kidney hilum's cross-clamping for 30 min before donation. After the kidneys' removal, the left ones were flushed with Histidine Tryptophan Ketoglutarate (HTK) preservation solution and transplanted after the 1.5 hour (in the meantime stored in melted ice). Venous blood samples were taken for the assessment of malondialdehyde (MDA), reduced glutathione (GSH), glutathioneperoxidase (GSHPx), antioxidative capacity of plasma (AOC), interleukin 6 (IL-6), and tumor-necrosis factor alfa (TNFalfa) prior to the nefrectomy, before application of ROS scavengers (TxII), and during the 120-minute period after the transplantation (TxL+TxII). RESULTS: There wasn't a significant difference neither in production of MDA, nor in the levels of GSH, GSHPx, AOC, IL6 and TNFalfa between the TxI and TxII groups. CONCLUSIONS: Based on our results, we cannot conclude that the intravenous application of ROS scavengers in given combination and amount, administered to the recipient in the period just before transplantation, is a useful protective mechanism against kidney damage during IRS (Fig. 3, Ref. 17). Full Text (Free, PDF) www.bmj.sk.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x aplikace a dávkování $7 D000975
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a scavengery volných radikálů $x aplikace a dávkování $x farmakologie $7 D016166
- 650 _2
- $a intravenózní infuze $7 D007262
- 650 _2
- $a transplantace ledvin $7 D016030
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a reperfuzní poškození $x metabolismus $x prevence a kontrola $7 D015427
- 650 _2
- $a Sus scrofa $7 D034421
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Třeška, Vladislav, $d 1957- $7 jn20000402436
- 700 1_
- $a Racek, Jaroslav, $d 1951- $7 jn20000402090
- 700 1_
- $a Kobr, Jiří, $d 1950- $7 xx0102261
- 700 1_
- $a Trefil, Ladislav $7 xx0099653
- 700 1_
- $a Hes, Ondřej, $d 1968- $7 jn20001103502
- 773 0_
- $w MED00000845 $t Bratislavské lekárske listy $g Roč. 108, č. 9 (2007), s. 385-387 $x 0006-9248
- 910 __
- $a ABA008 $b A 4 $y 7
- 990 __
- $a 20110223130814 $b ABA008
- 991 __
- $a 20130919101835 $b ABA008
- 999 __
- $a ok $b bmc $g 823380 $s 688807
- BAS __
- $a 3
- BMC __
- $a 2007 $b 108 $c 9 $d 385-387 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
- GRA __
- $a NR7913 $p MZ0
- LZP __
- $a 2011-2B/ewme